首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

Cancer Genetics
ISSN：2210-7762

Cancer Genetics

CANCER GENET-NY
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：较慢,6-12周
新锐分区：医学4区
年发文量：42
影响因子：2.1
JCR分区：Q3

基本信息

癌症遗传学的目标是发表关于癌症的细胞、遗传和分子方面的高质量科学论文，包括癌症易感性和临床诊断应用。感兴趣的具体领域包括描述良性和恶性疾病中新的染色体、分子或表观遗传学改变;鉴定和表征癌细胞中染色体重排或基因组改变的新实验室方法;遗传变化与病理和临床表现的相关性;和癌症易感性的分子遗传学。为了达到基础科学和临床多学科的读者，我们欢迎原来的完整长度的文章，审查，会议总结，简短的报告，和信件编辑。
2210-7762SCIE/Scopus收录
2.1
点击查看最新影响趋势>
10.5
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
GENETICS & HEREDITY 遗传学
4区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：GENETICS & HEREDITY
SCIE
Q3
114/192
学科：ONCOLOGY
SCIE
Q3
229/328
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：GENETICS & HEREDITY
SCIE
Q3
143/192
学科：ONCOLOGY
SCIE
Q3
234/328
35
42
点击查看年发文量趋势图>
9%较易较慢,6-12周-ONCOLOGY-GENETICS & HEREDITY
0%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
95.24%6.17%-
CiteScore：3.50
SJR：0.709
SNIP：0.438
学科类别分区排名百分位
大类：Biochemistry, Genetics and Molecular Biology
小类：Genetics
Q3
225 / 348
大类：Biochemistry, Genetics and Molecular Biology
小类：Cancer Research
Q3
165 / 233
大类：Biochemistry, Genetics and Molecular Biology
小类：Molecular Biology
Q3
295 / 410

期刊高被引文献

Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.04.062
Somatic mutation panels: Time to clear their names.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.04.065
Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.11.001
A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.09.005
Rapid detection of chromosomal translocation and precise breakpoint characterization in acute myeloid leukemia by nanopore long-read sequencing.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.08.005
Dysregulated expression of repetitive DNA in ER+/HER2- breast cancer.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.09.002
Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.03.002
Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.04.001
Single nucleotide polymorphism rs10889677 in miRNAs Let-7e and Let-7f binding site of IL23R gene is a strong colorectal cancer determinant: Report and meta-analysis.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.09.003
STK11 gene analysis reveals a significant number of splice mutations in Chinese PJS patients.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2018.11.008
p53 major hotspot variants are associated with poorer prognostic features in hereditary cancer patients.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.05.002
FANCM, RAD1, CHEK1 and TP53I3 act as BRCA-like tumor suppressors and are mutated in hereditary ovarian cancer.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.04.061
Molecular evaluation of BRAF V600 mutation and its association with clinicopathological characteristics: First findings from Indian malignant melanoma patients.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.01.003
Cytogenomic characterization of double minute heterogeneity in therapy related acute myeloid leukemia.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.08.001
Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2018.10.005
Multidisciplinary analysis of pediatric T-ALL: 9q34 gene fusions.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2018.12.002
Classic bladder exstrophy and adenocarcinoma of the bladder: Methylome analysis provide no evidence for underlying disease-mechanisms of this association.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.05.004
Expression deregulation of DNA repair pathway genes in gastric cancer.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.06.002
Chronic myelomonocytic leukemia with ETV6-ABL1 rearrangement and SMC1A mutation.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.07.004
Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.10.002
PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.06.001
Maintaining a methods database to optimize solid tumor tissue culture: Review of a 15-year database from a single institution.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.01.006
Uptake of genetic testing for germline BRCA1/2 pathogenic variants in a predominantly Hispanic population.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.04.063
Single-cell cloning of human T-cell lines reveals clonal variation in cell death responses to chemotherapeutics.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.06.003
Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.10.004
Untouchable genes in the human genome: Identifying ideal targets for cancer treatment.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.01.005
ATM whole gene deletion in an Italian family with hereditary pancreatic cancer: Challenges to cancer risk prediction associated with an 11q22.3 microdeletion.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.10.003
Confirmation of damaging effect of MSH2 c.2634+1G>C mutation on splicing, its classification and implications for counseling.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.08.002
RUNX1 deletion/amplification in therapy-related acute myeloid leukemia: A case report and review of the literature.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.07.006
Longitudinal whole-genome sequencing reveals the evolution of MPAL.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.11.007
Embryonal rhabdomyosarcoma in a patient with a germline CBL pathogenic variant.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2018.12.006
Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.09.001
MIR605 rs2043556 is associated with the occurrence of multiple primary tumors in TP53 p.(Arg337His) mutation carriers.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.11.005
A novel BRCA1 germline mutation promotes triple-negative breast cancer cells progression and enhances sensitivity to DNA damage agents.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.08.004
Variants in COL6A3 gene influence susceptibility to esophageal cancer in the Chinese population.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.07.003
Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.10.006
Identification of eight meta-signature miRNAs as potential biomarkers for oropharyngeal cancers.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2018.10.004
Novel pleiotropic BRCA2 pathogenic variants in Lebanese families.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2018.12.005
Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.12.001
Utility of copy number variants in the classification of intracranial ependymoma.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.11.003
Molecular and pathologic characterization of AML with double Inv(3)(q21q26.2).
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2018.08.007
Low ALK FISH positive metastatic non-small cell lung cancer (NSCLC) patients have shorter progression-free survival after treatment with ALK inhibitors.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.12.003
A unique case of complex variant translocation of t(6;9;22)(p22;q34;q11.2), der(19) in a newly diagnosed patient with chronic myeloid leukemia.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.06.008
A diagnosis of discernment: Identifying a novel ATRX mutation in myelodysplastic syndrome with acquired α-thalassemia.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.01.002
c.1227_1228dupGG (p.Glu410Glyfs), a frequent variant in Tunisian patients with MUTYH associated polyposis.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.10.007
Detection of a novel CBFB-MYH11 fusion transcript in acute myeloid leukemia M1 with inv(16)(p13q22).
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.07.005
Genome-wide isoform-level analysis reveals tumor-specific isoforms for lung adenocarcinoma diagnosis and prognosis.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2018.11.004
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.08.003
Cytogenetic profile of a representative cohort of young adults with de novo acute myéloblastic leukaemia in Morocco.
来源期刊：Cancer geneticsDOI：10.1016/J.CANCERGEN.2019.06.010
Acute lymphoblastic leukemia in a nine-year-old girl with isodicentric chromosome 15 syndrome.
来源期刊：Cancer geneticsDOI：10.1016/j.cancergen.2019.05.001

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACSMS HEALTH & FITNESS JOURNAL封面

ACSMS HEALTH & FITNESS JOURNAL

学科领域：医学
影响因子：1.8
中科院分区： 4区
ACTA BIOQUIMICA CLINICA LATINOAMERICANA封面

ACTA BIOQUIMICA CLINICA LATINOAMERICANA

学科领域：医学
影响因子：0.1
中科院分区： 4区
Acta Cardiologica Sinica封面

Acta Cardiologica Sinica

学科领域：医学
影响因子：1.8
中科院分区： 4区
Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca封面

Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca

学科领域：医学
影响因子：0.4
中科院分区： 4区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
GENETICS & HEREDITY 遗传学
4区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
GENETICS & HEREDITY 遗传学
4区
ONCOLOGY 肿瘤学
4区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
GENETICS & HEREDITY 遗传学
4区
ONCOLOGY 肿瘤学
4区
否
否